It's that time of year again. Our sister publication FierceBiotech has released its pick of the top 15 companies at the forefront of drug development. Biotech is a risky field and while not all of these companies will be as successful as they hope to be, you can bet at least a few on the list will make headlines as future acquisition targets or IPO-stage companies with commercial opportunities to pursue. Click here to see the 2008 Fierce 15 winners. List